NCT07057843Completed
Sequential Nutrition Intervention for Pancreatic Cancer Patients Undergoing CyberKnife Radiotherapy
Application Value of Sequential Nutrition Intervention Guided by Nutritional Risk Screening in CyberKnife Radiotherapy for Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 10 Jul 2025
Brief summary (registry, in English)
This study aims to evaluate the clinical value of a structured nutritional support program for patients with pancreatic cancer undergoing CyberKnife radiotherapy. The study compares a sequential nutrition intervention, guided by nutritional risk screening, against routine nutritional advice. The goal is to determine if the structured intervention can better improve patients' nutritional status, immune function, and quality of life, while reducing the rate of postoperative complications.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 1 Jul 2025
- Start date
- 1 Jun 2023
- Primary completion date
- 30 Jul 2024
- Lead sponsor
- The First Hospital of Hebei Medical University
- Diseases
- Pancreatic cancer
- NCT number
- NCT07057843
What you commit to
- Study type: Interventional
- Participants enrolled: 100
- From 1 Jun 2023 to the primary completion date, 30 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent malignancies of the digestive system.
- Long-term corticosteroid use.
Other illness
- Severe cognitive impairment hindering cooperation.
- History of liver, kidney, or hematological diseases.
- Comorbidities affecting drug metabolism or excretion (e.g., AIDS, active hepatitis).
Other
- Severe cardiovascular, hepatic, or renal dysfunction.
- Poor treatment compliance.
- Severe ascites or edema.
- Bedridden status precluding nutritional assessment.
Who the study is looking for
- Diagnosis of pancreatic cancer confirmed by pathological examination.
- Capacity for oral intake.
- Scheduled for CyberKnife treatment.
- Presence of malnutrition, defined by Nutritional Risk Screening 2002 (NRS2002) score ≥3.
- Expected survival \>6 months.
- Karnofsky Performance Status (KPS) score ≥60.
- Provided written informed consent.
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| First Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.